EDGAR Filing Documents for 0001047469-19-002022

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001047469-19-002022

Filing Date

2019-04-05

Accepted

2019-04-05 17:09:45

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2238374zs-3.htm	S-3	1450835
2	EX-1.2	a2238374zex-1_2.htm	EX-1.2	253631
3	EX-4.5	a2238374zex-4_5.htm	EX-4.5	508775
4	EX-4.7	a2238374zex-4_7.htm	EX-4.7	168720
5	EX-4.8	a2238374zex-4_8.htm	EX-4.8	185185
6	EX-4.9	a2238374zex-4_9.htm	EX-4.9	149291
7	EX-5.1	a2238374zex-5_1.htm	EX-5.1	33445
8	EX-23.1	a2238374zex-23_1.htm	EX-23.1	3890
9	EX-23.2	a2238374zex-23_2.htm	EX-23.2	5840
10	G76672KYI001.JPG	g76672kyi001.jpg	GRAPHIC	2750
11	G301614.JPG	g301614.jpg	GRAPHIC	26870
12	G911089.JPG	g911089.jpg	GRAPHIC	32661
	Complete submission text file	0001047469-19-002022.txt		2846883

Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104

Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000

Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)